Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Goff

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
JCO Oncology Practice|April 12, 2021
Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United StatesSoledad Jorge, Barbara A Goff, Heidi J Gray, et al.
Obstetrics and Gynecology|April 23, 2009
Factors affecting risk of mortality in women with vaginal cancerChirag A Shah, Barbara A Goff, Kimberly Lowe, et al.
Cancer Causes & Control : CCC|March 20, 2002
Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medicationsSascha Dublin, Mary Anne Rossing, Susan R Heckbert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
The Cost of Initial Care for Medicare Patients With Advanced Ovarian CancerRenata R Urban, Hao He, Rafael Alfonso-Cristancho, et al.
Cancer Genetics and Cytogenetics|May 14, 2008
Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancersKaren M Chisholm, Barbara A Goff, Rochelle Garcia, et al.
Gynecologic Oncology|November 20, 2009
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancerHeidi J Gray, Chirag A Shah, Ron E Swensen, et al.
American Journal of Obstetrics and Gynecology|May 30, 2006
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomyJulie D Lamb, Rochelle L Garcia, Barbara A Goff, et al.
Gynecologic Oncology|December 31, 2002
Evaluation of p27 in preinvasive and invasive malignancies of the cervixBarbara A Goff, Joshua Sallin, Rochelle Garcia, et al.
Obstetrics and Gynecology|August 24, 2011
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderlyMelissa M Thrall, Barbara A Goff, Rebecca Gaston Symons, et al.
American Journal of Obstetrics and Gynecology|November 2, 2005
A new curriculum for hysteroscopy training as demonstrated by an objective structured assessment of technical skills (OSATS)Amy L VanBlaricom, Barbara A Goff, Michael Chinn, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
JCO Oncology Practice|April 12, 2021
Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United StatesSoledad Jorge, Barbara A Goff, Heidi J Gray, et al.
Obstetrics and Gynecology|April 23, 2009
Factors affecting risk of mortality in women with vaginal cancerChirag A Shah, Barbara A Goff, Kimberly Lowe, et al.
Cancer Causes & Control : CCC|March 20, 2002
Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medicationsSascha Dublin, Mary Anne Rossing, Susan R Heckbert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
The Cost of Initial Care for Medicare Patients With Advanced Ovarian CancerRenata R Urban, Hao He, Rafael Alfonso-Cristancho, et al.
Cancer Genetics and Cytogenetics|May 14, 2008
Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancersKaren M Chisholm, Barbara A Goff, Rochelle Garcia, et al.
Gynecologic Oncology|November 20, 2009
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancerHeidi J Gray, Chirag A Shah, Ron E Swensen, et al.
American Journal of Obstetrics and Gynecology|May 30, 2006
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomyJulie D Lamb, Rochelle L Garcia, Barbara A Goff, et al.
Gynecologic Oncology|December 31, 2002
Evaluation of p27 in preinvasive and invasive malignancies of the cervixBarbara A Goff, Joshua Sallin, Rochelle Garcia, et al.
Obstetrics and Gynecology|August 24, 2011
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderlyMelissa M Thrall, Barbara A Goff, Rebecca Gaston Symons, et al.
American Journal of Obstetrics and Gynecology|November 2, 2005
A new curriculum for hysteroscopy training as demonstrated by an objective structured assessment of technical skills (OSATS)Amy L VanBlaricom, Barbara A Goff, Michael Chinn, et al.
Pageof 13